We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

FDA and CMS Make Case Before Congress for FDA Oversight of Laboratory Developed Tests

Susan D. Tiedy-Stevenson

Susan D. Tiedy-Stevenson,

Washington, D.C.

Janice Hogan

Jonathan Kahan

Yarmela Pavlovic

Randy Prebula

Erkang Ai

12 February 2016
On November 17, 2015, leaders from both the Food and Drug Administration (FDA) and the Centers for Medicare & Medicaid Services (CMS) testified before the U.S. House of Representatives Committee on Energy and Commerce, Subcommittee on Health regarding regulation of Laboratory Developed Tests, or LDTs.
Susan D. Tiedy-Stevenson

Susan D. Tiedy-Stevenson,

Washington, D.C.

Janice Hogan

Jonathan Kahan

Yarmela Pavlovic

Randy Prebula

Erkang Ai

Loading data